October 1, 2020, 07.05 PM
AstraZenecas Covid-19 vaccine study is under further investigation by the US Food and Drug Administration (FDA) after one participant experienced a serious illness. SHUTTERSTOCK/SCOTT CORNELLAstraZenecas Covid-19 vaccine study is under further investigation by the US Food and Drug Administration (FDA) after one participant experienced a serious illness.

WASHINGTON, KOMPAS.com – AstraZeneca's Covid-19 vaccine study is under further investigation by the US Food and Drug Administration (FDA) after one participant experienced a serious illness.

The FDA body will assess data from earlier trials of similar coronavirus vaccines developed by the same scientists, three sources familiar with the details told Reuters.

AstraZeneca’s Covid-19 vaccine trials in the US has been on hold since September 6 after a study participant in Britain fell ill with what was believed to be a rare spinal inflammatory disorder called transverse myelitis.

Read also: Clinical Trials of a Coronavirus Vaccine Back on Track

The widened scope of the FDA probe raises the likelihood of additional delays for what has been one of the most advanced Covid-19 vaccine candidates in development.

The requested data was expected to arrive this week, after which the FDA would need time to analyze it, two of the sources said.

Effective vaccines are seen as essential to help end a pandemic that has killed more than one million people worldwide.

The administration of President Donald Trump has pledged $1.2 billion to support the development of AstraZeneca's Covid-19 vaccine and secure 300 million doses for the United States.

Read also: AstraZeneca Boosts Coronavirus Vaccine Supply with New Deal

Other leading companies in the US vaccine race include Pfizer Inc, Moderna Inc and Johnson & Johnson.

Page:


Comment wisely and responsibly. Comments are entirely the responsibility of the commentator as regulated in the ITE Law
Report
Thank You! We have received your report. We will remove comments that conflict with the Community Guidelines and the ITE Law.

More Headlines

News
January 14, 2022, 04.16 PM

Two-Headed Baby Born in Indonesia’s Sumatera

Business
January 6, 2022, 03.59 PM

Jokowi Revokes Over 2,000 Coal Mining Permits

News
December 29, 2021, 09.42 PM

Indonesia Denies Entry to Rohingya Stranded at Sea

Business
December 29, 2021, 07.38 PM

Indonesia’s Bukalapak CEO Tenders Resignation

Close Ads X